 Emergent BioSolutions Inc. is cutting 132 jobs, or approximately 5 of its workforce in a reorganization that the company says will sharpen its strategic focus on core businesses. The biotech described its core businesses as medical countermeasures and commercial products, including NARCAN nasal spray, as well as contract development and manufacturing services. As part of ... The post Emergent BioSolutions to cut 5 of its workforce in reorganization effort appeared first on ForexTV... 